Brief report · 30 Jun 2026
Conference abstractPublished 2 Oct 2017
Mutagenic impurities in pharmaceuticals: ICH M7, purge factors and the Mirabilis project
Merck Sharp & Dohme, USA Lhasa Mirabilis, Cross-Pharma Consortiu
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Mutagenic impurities are a special category of impurities that can be present in active pharmaceutical ingredients. The understanding, detection, and control of MIs have received increasing industry and regulatory attention over the past decade. Originated by Teasdale in 2010, the concept of purge factor calculation to understand the fate of MIs in synthetic processes has been validated by various independent groups, including its application to a development project at MSD that was described in a recent publication. This approach can reduce the burden of analytical testing for MIs without compromising patient safety, provided a scientifically rigorous approach is taken, backed up by sufficient theoretical and/or analytical data. Moreover, specific reference to this method is provided in the accepted regulatory guidance âÂ?Â? ICH M7 Option 4 - which was released in 2014. This presentation provides some background to the concept of purge factor calculation and introduces a consortium-led initiative, the Lhasa Mirabilis Project. The Mirabilis consortium seeks to develop an industry-standardized approach, providing an expert and scientifically robust software for the automated calculation of purge factors for potentially mutagenic impurities in a synthetic route.
Subjects
ChemistryPharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Medicinal Chemistry.
Commentary · 29 Dec 2025
Accelerating Drug Discovery: Molecular Docking and Virtual Screening
Opinion · 29 Dec 2025
Pharmacophore Modeling: A Cornerstone of Drug Discovery
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalMedicinal Chemistry
- SubjectChemistry
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Mark McLaughlin”
